Contact Us | Visit iqvia.com | Français

Solutions for You to Drive Healthcare Forward

Pan-Canadian Pricing Alliance

QUARTERLY REPORTS EVALUATING THE IMPACT OF PCPA ON REIMBURSEMENT, AS WELL AS CUSTOMIZED MARKET ACCESS SOLUTIONS

  • Measuring time to listing, listing quality, and coverage by province
  • Tracking CDR & pCODR recommendations and implications of PCPA review on provincial formulary listings
  • Comparison of pre- vs. post-PCPA era
  • Analysis for each new drug, by indication

Health Access & Outcomes

Follows us on:

Privacy   |   Terms of Use    Copyright © 2017 IQVIA. All rights reserved.